IceCure Medical (ICCM) Gains from Sales and Divestitures (2025)
IceCure Medical (ICCM) reported Gains from Sales and Divestitures of $288764.0 for Q4 2025.
IceCure Medical (ICCM) has 1 years of Gains from Sales and Divestitures data on file, last reported at $288764.0 in Q4 2025.
- Quarterly Gains from Sales and Divestitures changed N/A year-over-year to $288764.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $288764.0 (changed N/A YoY) and the FY2025 annual result came in at $288764.0, changed N/A from the prior year.
- Gains from Sales and Divestitures was little changed at $288764.0 in Q4 2025 per ICCM's latest filing.
- Across five years, Gains from Sales and Divestitures topped out at $288764.0 in Q4 2025 and bottomed at $288764.0 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | IceCure Medical | 12.09 | -8.11 Mn | 295,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 288,764.00 |
| Dec 31, 2025 | 288,764.00 |